Basit öğe kaydını göster

Polymorphisms in the microsomal epoxide hydrolase gene: role in lung cancer susceptibility and prognosis

dc.contributor.authorIsbir, Turgay
dc.contributor.authorTurna, Akif
dc.contributor.authorGormus, Uzay
dc.contributor.authorCamlica, Hakan
dc.contributor.authorYaylim-Eraltan, Ilhan
dc.contributor.authorErkisi, Zelal
dc.date.accessioned2021-03-02T21:13:21Z
dc.date.available2021-03-02T21:13:21Z
dc.date.issued2010
dc.identifier.citationErkisi Z., Yaylim-Eraltan I., Turna A., Gormus U., Camlica H., Isbir T., "Polymorphisms in the microsomal epoxide hydrolase gene: role in lung cancer susceptibility and prognosis", TUMORI J, cilt.96, sa.5, ss.756-763, 2010
dc.identifier.issn0300-8916
dc.identifier.othervv_1032021
dc.identifier.otherav_05db7aea-7a09-4123-abd1-0bd5c8ab5cba
dc.identifier.urihttp://hdl.handle.net/20.500.12627/9807
dc.description.abstractAims and background. The aim of this study was to investigate the relationship between EPHXI exon 3 Tyr113His and exon 4 His139Arg polymorphisms, predicted microsomal epoxide hydrolase (mEH) activity, and lung cancer development. mEH is a protective enzyme involved in oxidative defences against a number of environmental chemicals and pollutants, but it is also responsible for the xenobiotic activation of carcinogens.
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titlePolymorphisms in the microsomal epoxide hydrolase gene: role in lung cancer susceptibility and prognosis
dc.typeMakale
dc.relation.journalTUMORI J
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume96
dc.identifier.issue5
dc.identifier.startpage756
dc.identifier.endpage763
dc.contributor.firstauthorID64213


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster